正电子放射性药物的应用现状与进展

陈开宇; 李新平; 陈盛新; 陈开宇; 李新平; 陈盛新

doi:10.3969/j.issn.1006-0111.2012.03.006

[1]

U.S. Food and Drug Administration. Positron Emission Tomography (PET): Questions and Answers about CGMP Regulations for PET Drugs［EB/OL］.(2009-12-9)［2012-4-30］. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/Manufacturing/ucm193476.htm.

[2]

金征宇. 医学影像学[M]. 第2版.北京:人民卫生出版社,2010:20.

[3]

张锦明, 田嘉禾. 国内正电子放射性药物发展现状简介[J]. 同位素,2006,19(4):240.

[4]

国家食品药品监督管理局,卫生部. 医疗机构制备正电子类放射性药品管理规定［EB/OL]. (2006-1-5)［2012-4-30］. http://www.sda.gov.cn/WS01/CL0058/9355.html.

[5]

Ido T, Wan CN, Fowler JS, et al. Fluorination with F₂:convenient synthesis of 2-deoxy-2-fluoro-D-glucose[J] J Org Chem,1977,42: 2341.

[6]

Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-［¹⁸F］-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution[J]. J Nucl Med,1986,27:235.

[7]

Fuchtner F, Steinbach J, Mading P. Basic previous term hydrolysis next term 2-［¹⁸F］fluoro-1,3,4,6-tetra-O-acetyl-image-glucose in the preparation of 2-［¹⁸F］fluoro-2-deoxy-Image-glucose[J]. Appl Radiat Isot,1996,47:61.

[8]

Shankar V, Lilja S, Brigitte V. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: What is new?[J]. Semin Nucl Med,2011, 41: 246.

[9]

International Atomic Energy Agency. Nuclear Technology Review 2010［R/OL］.(2010-8-10)［2012-4-30］.http://www.iaea.org/About/Policy/GC/GC54/GC54InfDocuments/English/gc54inf-3_en.pdf.

[10]

U.S. Food and Drug Administration. Drug information［DB/OL］. ［2012-4-30］. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm.

[11]

中华医学会核医学分会. 2010年全国核医学现状普查[J].中华核医学杂志,2010,30(6):428.

[12]

梁银杏,叶桦. 关于我国正电子放射性药品新药注册管理的建议[J]. 中国新药与临床杂志,2012,31(2):68.

[13]

张锦明. 正电子放射性药物进展[J]. 中华核医学杂志,2003,23(5):315.

[14]

周克,杨勤,向燕. 正电子放射性药物的现状与进展[J]. 西南军医,2005,7(2):47.

[15]

卫生部. 中华人民共和国卫生部批准配置PET／CT医疗机构名单[J]. 中华核医学杂志,2010,30(6):418.

[16]

卫生部. 2011~2015年全国正电子发射型断层扫描仪配置规划［EB/OL］.(2011-11-2)［2012-4-30］http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohghcws/s3585/201111/53257.htm.

[17]

国家食品药品监督管理局,卫生部. 正电子类放射性药品质量控制指导原则［EB/OL］.(2006-1-5)［2012-4-30］. http://www.sda.gov.cn/WS01/CL0058/9355_6.html.

[18]

USP 32-NF 27［S］. 2008: 2406.